Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical precancer and cancer at the start of a human papillomavirus vaccination programme: The CIN3+ plus study

The Swiss Federal Office of Public Health has recommended vaccination against human papillomavirus (HPV) to prevent cervical cancer since 2008. To establish monitoring of the future public health impact of vaccination, baseline population-based data are required.